A detailed history of Bowling Portfolio Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Bowling Portfolio Management LLC holds 4,712 shares of LLY stock, worth $3.52 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
4,712
Previous 5,368 12.22%
Holding current value
$3.52 Million
Previous $1.74 Million 12.41%
% of portfolio
0.42%
Previous 0.44%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 04, 2022

SELL
$296.48 - $337.87 $194,490 - $221,642
-656 Reduced 12.22%
4,712 $1.52 Million
Q2 2022

Jul 21, 2022

BUY
$278.73 - $327.27 $1.5 Million - $1.76 Million
5,368 New
5,368 $1.74 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $972,442 - $1.26 Million
-5,386 Closed
0 $0
Q1 2021

Apr 19, 2021

SELL
$164.32 - $212.72 $939,910 - $1.22 Million
-5,720 Reduced 51.5%
5,386 $1.01 Million
Q4 2020

Jan 15, 2021

SELL
$130.46 - $172.63 $124,458 - $164,689
-954 Reduced 7.91%
11,106 $1.88 Million
Q3 2020

Oct 15, 2020

BUY
$146.22 - $169.13 $1.76 Million - $2.04 Million
12,060 New
12,060 $1.79 Million
Q2 2019

Jul 25, 2019

SELL
$110.79 - $129.32 $3.4 Million - $3.96 Million
-30,644 Closed
0 $0
Q1 2019

Apr 18, 2019

SELL
$111.31 - $131.02 $108,749 - $128,006
-977 Reduced 3.09%
30,644 $3.98 Million
Q4 2018

Jan 17, 2019

SELL
$105.9 - $118.64 $66,611 - $74,624
-629 Reduced 1.95%
31,621 $3.66 Million
Q3 2018

Oct 18, 2018

SELL
$85.86 - $107.31 $578,438 - $722,947
-6,737 Reduced 17.28%
32,250 $3.46 Million
Q2 2018

Aug 06, 2018

BUY
$75.7 - $86.88 $2.95 Million - $3.39 Million
38,987 New
38,987 $3.33 Million
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $3.79 Million - $4.47 Million
-51,062 Closed
0 $0
Q4 2017

Jan 22, 2018

BUY
$81.94 - $87.89 $4.18 Million - $4.49 Million
51,062
51,062 $4.31 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bowling Portfolio Management LLC Portfolio

Follow Bowling Portfolio Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bowling Portfolio Management LLC with notifications on news.